🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

And the 2025 Society for Immunotherapy of Cancer #Sparkathon has come to a close! Many thanks to Jennifer Guerriero, PhD Marco Ruella and the @sitccancer team for the fantastic organization. Congrats to all "Sparkies" for the top-notch science and great presentations. The future of immunotherapy is bright my

It is truly the highlight of my career to organize the Society for Immunotherapy of Cancer Sparkathon mentoring program for early career scientists and physicians together with Marco Ruella. This class of Spakies is incredible and inspiring. The future of medicine and science is so bright. ✨

Honored to organize with Drs. Tom Marron, Ira Mellman Solange Peters the 2026 Keystone Symposia #CancerImmunotherapy: Mechanisms, Clinical Advances and Combinations, this October! Join us in Québec! keysym.us/KSCancerImmune… #KSCancerImmune26

Join us for the April MyeloidNetwork Seminar Series featuring Leila Akkari

A huge congratulations to Dan Michaud, PhD from the #GuerrieroLab Brigham and Women's Hospital who was awarded first place in Basic Science on his work harnessing macrophages to treat solid tumors at the Society for Immunotherapy of Cancer Sparkathon program. 🌟🥇🎉

Guerriero Lab Spotlight: Dr. Adam Nelson from Brigham and Women’s Department of Surgery has been awarded a Scholar-in-training award for the AACR 2025 annual meeting on his work "Combined anti-CSF-1R and anti-TIM-3 overcomes immune-mediated mechanisms of PARP inhibitor (PARPi) resistance in

Guerriero Lab Spotlight: Kenichi Shimada from Brigham and Women’s Department of Surgery and Harvard Medical School has been selected to give an oral presentation at the AACR 2025 annual meeting on his work "An estrogen receptor signaling transcriptional program linked to immune evasion in human hormone

This is such great news. Thank you Cancer Research Institute for this incredibly important investment in our early career scientists and physicians. 👏🏼

With NIH cuts making research funding harder to secure, CRI is stepping up! We’re committing $2.5M to support 10 additional postdocs so that promising #CancerResearch doesn’t get left behind. Learn more: bit.ly/4iEQNsJ

I am incredibly humbled by the response to this fundraising campaign. Thank you to everyone who donated. The Guerriero lab is leading the field in discovering new ways to activate your body's own immune system to cure cancer. Every dollar matters. Thank you so much for your

Incredibly grateful for support from Brigham and Women's Hospital and Mass General Brigham Innovation on a novel strategy the Guerriero Lab Brigham and Women’s Department of Surgery is pioneering to eliminate tumor promoting macrophages in tumors. Eliminating these macrophages should make chemo- and immuno-therapy work better across

SITC members can submit nominations for SITC Annual Awards, Academy of Immuno-Oncology and 40th Anniversary Awards until May 1! Honorees will be recognized at SITC’s 40th Anniversary Annual Meeting: sitcancer.org/aboutsitc/awar… #sitc25

📢Thrilled this has come together for #RadRes2025: Inaugural Society for Immunotherapy of Cancer Radiation Research Society Symposium🎇 Because the immune system + #radbio need each other😉🫂 Amazing speakers (all on X!!😊)‼️ Sandra Demaria & Jennifer Guerriero, PhD -SITC Timothy Chan & Shane Harding -RRS 🙏#radonc

Excited to present at #AACR2025 in Chicago next week! I’ll be speaking in the mini-symposium “Overcoming Tumor Immune Suppression” on Sunday, April 27 (3–5 PM, Room S404), based on my work with Jennifer Guerriero, PhD. Hope to see you there!

Don't miss Dr. Jennifer Guerriero (Jennifer Guerriero, PhD) discussing the complexities of tumor-associated macrophages for anti-cancer therapy at this year's AACR. #AACR25 #DanaFarberAACR25

Dr. Kenichi Shimada (Kenichi Shimada), a researcher in the Guerriero Lab, will share his work on an estrogen receptor signaling transcriptional program linked to immune evasion in human hormone receptor-positive #BreastCancer at #AACR25. Jennifer Guerriero, PhD AACR

Dr. Adam Nelson, is a rising star in the Guerriero Lab, he was awarded the Scholar-in-Training Award at the AACR 2025 annual meeting. Check out his research on the 28th 👉"Combined anti-CSF-1R and anti-TIM-3 overcomes immune-mediated mechanisms of PARP inhibitor (#PARPi)

I am thrilled to share that the first preprint from my lab is now available on bioRxiV! In this study, our team elucidates the role of autocrine ligands in the aberrant behavior of oncogene-driven lung cancer. biorxiv.org/content/10.110…

So grateful for @gulleyj1’s mentorship, support and friendship. This picture made my heart so happy. ❤️ zoom in on the shirt! Supporting the #GuerrieroLab Society for Immunotherapy of Cancer